News Guest User 12/22/23 Guest User 12/22/23 Predica’s highlights of 2023 Read More Guest User 12/12/23 Guest User 12/12/23 Public Private Partnership allowance for the development of a better treatment of cervical cancer Read More Guest User 12/7/23 Guest User 12/7/23 Winner of the Investor Forum 2023 at Dutch Life Sciences conference Read More Guest User 11/13/23 Guest User 11/13/23 Dutch Life Sciences Conference Read More Guest User 11/1/23 Guest User 11/1/23 32nd Conference of the German Society for Cytology Read More Guest User 10/30/23 Guest User 10/30/23 Launch of “Targeted Microbiome Profiling”, a pathway-based microbiome profiling service for health and disease. Read More Guest User 9/12/23 Guest User 9/12/23 Pitch video - BANN meeting Read More Guest User 8/11/23 Guest User 8/11/23 Predica’s Team outing Read More Guest User 7/12/23 Guest User 7/12/23 The healthcare professionals' perspective Read More Guest User 6/30/23 Guest User 6/30/23 Take-off phase 2 funding to accelerate development of our cervical (pre)cancer prediction test Read More Guest User 6/28/23 Guest User 6/28/23 SMB Network Meeting #DareToAsk Read More Guest User 6/19/23 Guest User 6/19/23 Successful event hosted by Techleapnl, Radboud University, Radboudumc and the Gemeente Nijmegen Read More Guest User 6/15/23 Guest User 6/15/23 The power of Predica Diagnostics‘s targeted RNA sequencing technology Read More Guest User 4/21/23 Guest User 4/21/23 Predica Diagnostics joined Dutch companies at Mid Tech 2023, Minnesota Read More Guest User 3/4/23 Guest User 3/4/23 Today is international HPV awareness day! Read More Guest User 2/11/23 Guest User 2/11/23 We had a fantastic time at EUROGIN Conference 2023 in Bilbao Read More Guest User 12/22/22 Guest User 12/22/22 Merry Christmas and a Happy New Year Read More Guest User 12/2/22 Guest User 12/2/22 CiRNAseq analysis of tumors to predict brain tumor behaviour and identify targets for personalized treatment Read More Guest User 11/15/22 Guest User 11/15/22 Eurostars EU funding for disruptive technologies in cervical cancer screening secured. Read More Guest User 7/26/22 Guest User 7/26/22 Press Release - July 26, 2022 Read More Newer Posts Older Posts
Guest User 12/12/23 Guest User 12/12/23 Public Private Partnership allowance for the development of a better treatment of cervical cancer Read More
Guest User 12/7/23 Guest User 12/7/23 Winner of the Investor Forum 2023 at Dutch Life Sciences conference Read More
Guest User 10/30/23 Guest User 10/30/23 Launch of “Targeted Microbiome Profiling”, a pathway-based microbiome profiling service for health and disease. Read More
Guest User 6/30/23 Guest User 6/30/23 Take-off phase 2 funding to accelerate development of our cervical (pre)cancer prediction test Read More
Guest User 6/19/23 Guest User 6/19/23 Successful event hosted by Techleapnl, Radboud University, Radboudumc and the Gemeente Nijmegen Read More
Guest User 6/15/23 Guest User 6/15/23 The power of Predica Diagnostics‘s targeted RNA sequencing technology Read More
Guest User 4/21/23 Guest User 4/21/23 Predica Diagnostics joined Dutch companies at Mid Tech 2023, Minnesota Read More
Guest User 2/11/23 Guest User 2/11/23 We had a fantastic time at EUROGIN Conference 2023 in Bilbao Read More
Guest User 12/2/22 Guest User 12/2/22 CiRNAseq analysis of tumors to predict brain tumor behaviour and identify targets for personalized treatment Read More
Guest User 11/15/22 Guest User 11/15/22 Eurostars EU funding for disruptive technologies in cervical cancer screening secured. Read More
